NSG500 Module 7 Discussion Latest 2021 (Respiratory Tract Infections)
Module 7 Discussion
Module VII: Respiratory Tract Infections
When faced with a choice between 2 or more possible answers, using a “STEPS” analysis may be a useful clinical decision making tool. The goal is to provide information for each agent and compare the results to aid in your decision.
S: safety – are there any serious drug interactions* Possible serious side effects or adverse drug reactions?
T – tolerability – consider any adverse drug effects or side effects that may be concerning to the patient such as: diarrhea, headaches, rash, etc.
E – efficacy – is one agent more efficacious than the other for the infection?
P – price – does the patient have insurance? will cost inhibit adherence or access to the medications’
S – simplicity – which regimen is simpler* Once a day dosing will likely have better adherence rates than three times a day dosing. Also, three days of an antibiotic may be preferable to 7-10 days. Depending on the drug you choose, the frequency and duration will vary.
Here’s an example table
Drug 1
Safety: Moderate drug interactions Tolerability: Diarrhea
Efficacy : Similar Price/Preference: $100/7 days
Drug 1
No drug interactions / serious ADRs Diarrhea, headaches
$30/3 days
Simplicity 7 days, once daily dosing 3 days, BID dosing
1. Which one would you choose and why?
2. Identify the available treatment strategies for CAP in an adult outpatient with comorbidities. Create your own “steps” analysis comparing the use of the available treatment regimens. Be prepared to compare and contrast your ideas with your classmates.
Reference: Evaluating the safety and effectiveness of new drugs
Having Trouble Meeting Your Deadline?
Get your assignment on NSG500 Module 7 Discussion Latest 2021 (Respiratory Tract Infections) completed on time. avoid delay and – ORDER NOW
